Qiushi Fu
Director/Board Member bei THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED
Profil
Dr. Qiushi Fu is an Independent Non-Executive Director at The United Laboratories International Holdings Ltd.
and a Partner at Shanghai Lichen Private Equity Management Co. , Ltd.
He is on the Board of Directors at The United Laboratories International Holdings Ltd.
Dr. Fu was previously employed as a Principal by Roche Diagnostic Systems, Inc. and a Principal by Shenzhen SiBiono GeneTech Co. Ltd.
He also served on the board at Eureka Therapeutics, Inc. and Shanghai Medicilon, Inc. He received his undergraduate degree from Peking University, a graduate degree from Peking University, an MBA from London Business School and a doctorate degree from the University of Illinois.
Aktive Positionen von Qiushi Fu
| Unternehmen | Position | Beginn |
|---|---|---|
| THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED | Director/Board Member | 30.06.2023 |
| Shanghai Lichen Private Equity Management Co. , Ltd. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Qiushi Fu
| Unternehmen | Position | Ende |
|---|---|---|
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Director/Board Member | - |
Roche Diagnostic Systems, Inc.
 Roche Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Roche Diagnostic Systems, Inc. develops and manufactures diagnostic devices. The company is based in Indianapolis, IN. | Corporate Officer/Principal | - |
Shenzhen SiBiono GeneTech Co. Ltd.
 Shenzhen SiBiono GeneTech Co. Ltd. Medical/Nursing ServicesHealth Services Part of Benda Pharmaceutical, Inc., Shenzhen SiBiono GeneTech Co. Ltd. is a private company that develops gene therapy products. The company is based in Shenzhen, China. The Chinese company was founded by Wei-Wei Zhang. | Corporate Officer/Principal | - |
| SHANGHAI MEDICILON INC. | Director/Board Member | - |
Ausbildung von Qiushi Fu
| Peking University | Graduate Degree |
| University of Illinois | Doctorate Degree |
| London Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED | Health Technology |
| SHANGHAI MEDICILON INC. | Commercial Services |
| Private Unternehmen | 4 |
|---|---|
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Health Technology |
Shenzhen SiBiono GeneTech Co. Ltd.
Shenzhen SiBiono GeneTech Co. Ltd. Medical/Nursing ServicesHealth Services Part of Benda Pharmaceutical, Inc., Shenzhen SiBiono GeneTech Co. Ltd. is a private company that develops gene therapy products. The company is based in Shenzhen, China. The Chinese company was founded by Wei-Wei Zhang. | Health Services |
Roche Diagnostic Systems, Inc.
Roche Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Roche Diagnostic Systems, Inc. develops and manufactures diagnostic devices. The company is based in Indianapolis, IN. | Health Technology |
| Shanghai Lichen Private Equity Management Co. , Ltd. |
